Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Doseology Sciences is a life sciences company based in British Columbia, Canada, specializing in the development of mushroom-based wellness products and mental health solutions. The company focuses on the functional fungi market, offering a range of tinctures and powders formulated with Lion's Mane, Reishi, Cordyceps, and other adaptogens to support cognitive function and stress management. While the company initially pursued a strategy involving psilocybin-based research and psychedelic clinics, it has pivoted primarily toward the consumer packaged goods (CPG) sector. Doseology's products are designed to integrate into daily routines to enhance mental clarity and overall well-being. The company is publicly traded on the Canadian Securities Exchange and continues to explore the intersection of mycological science and mental health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Doseology Sciences.